Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen

BACKGROUND: Synuclein gamma (SNCG), initially identified as a breast cancer specific gene, is aberrantly expressed in many different malignant tumors but rarely expressed in matched nonneoplastic adjacent tissues. In this study, we investigated the prognostic potential of SNCG in colon cancer partic...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Caiyun, Dong, Bin, Lu, Aiping, Qu, Like, Xing, Xiaofang, Meng, Lin, Wu, Jian, Eric Shi, Y, Shou, Chengchao
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912867/
https://www.ncbi.nlm.nih.gov/pubmed/20604972
http://dx.doi.org/10.1186/1471-2407-10-359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912867/
https://www.ncbi.nlm.nih.gov/pubmed/20604972
http://dx.doi.org/10.1186/1471-2407-10-359

Ejemplares similares